These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34082967)

  • 21. Application of a mechanically responsive, inflammatory macrophage-targeted dual-sensitive hydrogel drug carrier for atherosclerosis.
    Yao SY; Shen ML; Li SJ; Wu XD; Zhang MM; Ma LN; Li YP
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110718. PubMed ID: 31846890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy.
    Zhu L; Zhong Y; Yan M; Ni S; Zhao X; Wu S; Wang G; Zhang K; Chi Q; Qin X; Li C; Huang X; Wu W
    ACS Appl Mater Interfaces; 2024 Jun; 16(25):32027-32044. PubMed ID: 38867426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
    Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
    Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil membrane biomimetic delivery system (Ptdser-NM-Lipo/Fer-1) designed for targeting atherosclerosis therapy.
    Li W; Liu C; Wang S; Liu N
    IET Nanobiotechnol; 2023 Jun; 17(4):387-395. PubMed ID: 37183611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect.
    Sha X; Dai Y; Chong L; Wei M; Xing M; Zhang C; Li J
    J Nanobiotechnology; 2022 Dec; 20(1):506. PubMed ID: 36456996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomimetic oral targeted delivery of bindarit for immunotherapy of atherosclerosis.
    Yin L; Peng C; Tang Y; Yuan Y; Liu J; Xiang T; Liu F; Zhou X; Li X
    Biomater Sci; 2020 Jul; 8(13):3640-3648. PubMed ID: 32458838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis.
    Tang D; Wang Y; Wijaya A; Liu B; Maruf A; Wang J; Xu J; Liao X; Wu W; Wang G
    Regen Biomater; 2021 Aug; 8(4):rbab033. PubMed ID: 34285811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ROS-Responsive Polymeric Micelle for Improving Pesticides Efficiency and Intelligent Release.
    Li R; Xie H; Zhang C; Sun Y; Yin H
    J Agric Food Chem; 2020 Aug; 68(34):9052-9060. PubMed ID: 32806117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.
    Alaarg A; Senders ML; Varela-Moreira A; Pérez-Medina C; Zhao Y; Tang J; Fay F; Reiner T; Fayad ZA; Hennink WE; Metselaar JM; Mulder WJM; Storm G
    J Control Release; 2017 Sep; 262():47-57. PubMed ID: 28700897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric micelles with dual thermal and reactive oxygen species (ROS)-responsiveness for inflammatory cancer cell delivery.
    Tang M; Hu P; Zheng Q; Tirelli N; Yang X; Wang Z; Wang Y; Tang Q; He Y
    J Nanobiotechnology; 2017 May; 15(1):39. PubMed ID: 28511687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in mice.
    Chen G; Deng H; Song X; Lu M; Zhao L; Xia S; You G; Zhao J; Zhang Y; Dong A; Zhou H
    Biomaterials; 2017 Nov; 144():30-41. PubMed ID: 28820966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management.
    Wang Y; Zhang K; Qin X; Li T; Qiu J; Yin T; Huang J; McGinty S; Pontrelli G; Ren J; Wang Q; Wu W; Wang G
    Adv Sci (Weinh); 2019 Jun; 6(12):1900172. PubMed ID: 31380165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines.
    Gao C; Huang Q; Liu C; Kwong CHT; Yue L; Wan JB; Lee SMY; Wang R
    Nat Commun; 2020 May; 11(1):2622. PubMed ID: 32457361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release.
    Yin W; Ke W; Chen W; Xi L; Zhou Q; Mukerabigwi JF; Ge Z
    Biomaterials; 2019 Mar; 195():63-74. PubMed ID: 30612064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis.
    Wu C; Mao J; Wang X; Yang R; Wang C; Li C; Zhou X
    J Nanobiotechnology; 2023 Aug; 21(1):271. PubMed ID: 37592345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of simvastatin-loaded polymeric micelles on human osteoblast-like MG-63 cells.
    Liu X; Li X; Zhou L; Li S; Sun J; Wang Z; Gao Y; Jiang Y; Lu H; Wang Q; Dai J
    Colloids Surf B Biointerfaces; 2013 Feb; 102():420-7. PubMed ID: 23006576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROS-Activated Ratiometric Fluorescent Polymeric Nanoparticles for Self-Reporting Drug Delivery.
    Zhang M; Song CC; Su S; Du FS; Li ZC
    ACS Appl Mater Interfaces; 2018 Mar; 10(9):7798-7810. PubMed ID: 29424527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.
    Ye S; Wang F; Fan Z; Zhu Q; Tian H; Zhang Y; Jiang B; Hou Z; Li Y; Su G
    ACS Appl Mater Interfaces; 2019 May; 11(17):15262-15275. PubMed ID: 30964624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox imbalance of red blood cells impacts T lymphocyte homeostasis: implication in carotid atherosclerosis.
    Profumo E; Buttari B; Petrone L; Straface E; Gambardella L; Pietraforte D; Genuini I; Capoano R; Salvati B; Malorni W; Riganò R
    Thromb Haemost; 2011 Dec; 106(6):1117-26. PubMed ID: 22071772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.